Domestic Pharmaceutical Logistics and FOB Destination Delivery

This contract governs the domestic transportation and delivery of pharmaceuticals under FOB Destination terms, where custody and risk of loss remain with the contractor until the goods are formally accepted by the recipient. The contractor is responsible for the secure, timely, and compliant movement of pharmaceutical products from origin to the designated delivery point, ensuring all regulatory, handling, and temperature control requirements are met throughout the supply chain. The contract is classified under NAICS code 484220, indicating a focus on general freight trucking, and is structured as a subcontract under the Defense Logistics Agency, part of the Department of Defense, reflecting the sensitive and mission-critical nature of the shipments. The contract is set to be performed nationwide with no specific place of performance defined, allowing flexibility for delivery to various military and federal facilities across the United States. The award is tied to contract SPS2DX25D8022, with delivery order SPE2D926F7327, and is intended to support the DLA’s logistical needs for medical supplies. Although the solicitation details and set-aside information are not provided, the use of FOB Destination terms clearly places the obligation on the contractor to manage all logistical risks until physical acceptance by the end recipient, underscoring the importance of documentation, tracking, and chain of custody for pharmaceuticals. The contract was posted on July 14, 2026, and execution is expected to align with ongoing Defense Department healthcare supply requirements.